< Key Hightlight >

MARKET OUTLOOK

As per Triton’s research report, the global market for infertility testing and treatment is anticipated to register growth at a CAGR of 10.15% over the forecast period of 2021-2028. 

Stress and infertility are considered to be linked. For example, stress causes an involuntary body response, including a flood of hormones that elevate heart rate, increasing blood pressure. Here, chronic stress can create a hormonal imbalance. Hence, growth in stress and lifestyle diseases are supporting the development of the studied market. 

Additionally, technological advancements in time-lapse technology, coupled with advances in embryo biopsy and genetic screening, are generating new opportunities for the infertility testing and treatment market. However, the high cost of these treatments negatively impacts the global market’s growth. 

REGIONAL OUTLOOK

The global infertility testing and treatment market covers North America, Asia-Pacific, Latin America, Europe, Middle East and Africa regions. 

Globally, the Asia-Pacific is anticipated to witness the fastest growth rate in the infertility testing and treatment market over the forecast period. This growth can be attributed to the surge in the adoption of fertility procedures and the rise in fertility tourism. In the region, South Korea, Singapore, India, and Thailand are some of the widely known medical tourism destinations, owing to affordable costs compared to other nations. Additionally, Japan and China are major countries popular for infertility testing and treatments. 

Furthermore, the rise in healthcare awareness and availability of skilled professionals is likely to enhance the demand for these treatments, thereby augmenting the growth of the infertility testing and treatment market. 

COMPETITIVE OUTLOOK

The key companies in the infertility testing and treatment market comprise Progyny, Cook Medical Inc, Ferring Pharmaceuticals, Fujifilm Irvine Scientific, Olympus Corporation, EMD Group (Merck KGAA), Cooper Surgical, Vitrolife AB, Halotech DNA, Create Fertility Centre, Endo International Plc, Labotect GmbH, Genea Ltd, Adorfem, and Bangkok IVF Center.   

Cook Medical Inc is a medical device company engaged in developing, manufacturing, and distributing devices for minimally invasive drugs. Its product portfolio includes needles, balloons, grafts, feeding tubes, plugs, and wire guides, among others. The company offers products and services in various areas, such as bariatric, gynecology, urology, colorectal surgery, plastic surgery, neurosurgery, and others. Besides, it markets its products directly and through a network of distributors and hospitals globally. It is headquartered in the United States.